$MEIP MEI Pharma, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MEI Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MEI Pharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in MEI Pharma, Inc. for free.
IRS Number: 510407811
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: MEIP
Company Address: 11455 EL CAMINO REAL SUITE 250 SAN DIEGO 92130
Phone number: 858-369-7100
Former name: MARSHALL EDWARDS INC, date of change: 2003-09-02
Market Capitalization: $57.00M
Prev close: $1.55
Average Daily Volume: 252,021
Days Low: $1.53
Year Low: $0.87
Year High: $2.28
MEI Pharma, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2021 | MEIP | MEI Pharma, Inc. | GHALIE RICHARD G | Chief Medical Offic ... | Option Exercise | A | 3.55 | 75,000 | 266,250 | 75,000 | |
| Feb 24 2021 | MEIP | MEI Pharma, Inc. | DRISCOLL FREDERICK W | Director | Sell | S | 4.03 | 25,000 | 100,625 | 37,500 | 62.5 K to 37.5 K (-40.00 %) |
| Jul 27 2020 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | M | 1.57 | 12,000 | 18,840 | 275,500 | |
| Jul 27 2020 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Buy | M | 1.57 | 12,000 | 18,840 | 453,632 | 441.6 K to 453.6 K (+2.72 %) |
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | Reynolds Thomas C | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | DRISCOLL FREDERICK W | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | Urso David M | Chief Operating Off ... | Option Exercise | A | 3.49 | 525,000 | 1,832,250 | 525,000 | |
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | Urso David M | Chief Operating Off ... | Grant | A | 0.00 | 50,000 | 0 | 74,106 | 24.1 K to 74.1 K (+207.42 %) |
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 3.49 | 230,000 | 802,700 | 230,000 | |
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | HOWSON TAMAR D | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Option Exercise | A | 3.49 | 230,000 | 802,700 | 230,000 | |
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | Clemens Kevan | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 |